Advertisement

Strahlentherapie bei Metastasen

  • Jürgen DunstEmail author
  • Dirk Bauerschlag
  • Nicolai Maass
  • David Krug
Gynäkologie aktuell

Zusammenfassung

Die Strahlentherapie stellt einen der Grundpfeiler der Behandlung von Patienten mit onkologischen Erkrankungen dar. Auch in der palliativen Therapiesituation ist die Bestrahlung insbesondere von Patienten mit Hirn- und Knochenmetastasen fest etabliert. Technologische Neuerungen wie auch neue Herangehensweisen im Verständnis von onkologischen Erkrankungen wie das Konzept der Oligometastasierung stellen besondere Anforderungen an die Strahlentherapie im interdisziplinären Kontext. Vor diesem Hintergrund fasst der Artikel den Stellenwert der Strahlentherapie für die Behandlung von Patientinnen mit metastasiertem Mammakarzinom zusammen.

Schlüsselwörter

Brustkrebs Knochenmetastasen Hirnmetasasen Radiochirurgie Oligometastasen 

Radiotherapy of metastases

Abstract

Radiotherapy is one of the cornerstones in the treatment of patients with malignant diseases. Even in the palliative treatment setting, irradiation is firmly established as a treatment option, especially for patients with brain and bone metastases. Technological advances as well as changing paradigms in the understanding of oncological diseases, such as the concept of oligometastatic disease, place special demands on radiotherapy in an interdisciplinary context. Against this background this article summarizes the role of radiotherapy in the treatment of patients with metastatic breast cancer.

Keywords

Breast cancer Bone metastases Brain metastases Radiosurgery Oligometastases 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

J. Dunst, D. Bauerschlag, N. Maass und D. Krug geben an, dass kein Interessenkonflikt besteht.

Die OLIGOMA-Studie ist eine von den Autoren geleitete und von der Ethikkommission Kiel begutachtete Multizenterstudie.

Literatur

  1. 1.
    Dovedi SJ, Adlard AL, Lipowska-Bhalla G et al (2014) Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res 74:5458–5468.  https://doi.org/10.1158/0008-5472.CAN-14-1258 CrossRefPubMedGoogle Scholar
  2. 2.
    Farquhar C, Marjoribanks J, Lethaby A, Azhar M (2016) High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database Syst Rev 64:129–183.  https://doi.org/10.1002/14651858.CD003139.pub3 CrossRefGoogle Scholar
  3. 3.
    Golden EB, Chhabra A, Chachoua A et al (2015) Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol 16:795–803.  https://doi.org/10.1016/S1470-2045(15)00054-6 CrossRefPubMedGoogle Scholar
  4. 4.
    Gondi V, Pugh SL, Tomé WA et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32:3810–3816.  https://doi.org/10.1200/JCO.2014.57.2909 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10CrossRefGoogle Scholar
  6. 6.
    Herrera FG, Bourhis J, Coukos G (2017) Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J Clin 67:65–85.  https://doi.org/10.3322/caac.21358 CrossRefPubMedGoogle Scholar
  7. 7.
    Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1040–1048.  https://doi.org/10.1016/S1470-2045(17)30414-X CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Martin AM, Cagney DN, Catalano PJ et al (2017) Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol 3:1069–1077.  https://doi.org/10.1001/jamaoncol.2017.0001 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Mulvenna P, Nankivell M, Barton R et al (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 388:2004–2014.  https://doi.org/10.1016/S0140-6736(16)30825-X CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Palma DA, Olson RA, Harrow S et al (2018) Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial. Int J Radiat Oncol Biol Phys 102:S3–S4.  https://doi.org/10.1016/j.ijrobp.2018.06.105 CrossRefGoogle Scholar
  11. 11.
    Postow MA, Callahan MK, Barker CA et al (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366:925–931.  https://doi.org/10.1056/NEJMoa1112824 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Salama JK, Milano MT (2014) Radical irradiation of extracranial oligometastases. J Clin Oncol 32:2902–2912.  https://doi.org/10.1200/JCO.2014.55.9567 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Schlampp I, Rieken S, Habermehl D et al (2014) Stability of spinal bone metastases in breast cancer after radiotherapy: a retrospective analysis of 157 cases. Strahlenther Onkol 190:792–797.  https://doi.org/10.1007/s00066-014-0651-z CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Scorsetti M, Franceschini D, De Rose F et al (2016) Stereotactic body radiation therapy: a promising chance for oligometastatic breast cancer. Breast 26:11–17.  https://doi.org/10.1016/j.breast.2015.12.002 CrossRefPubMedGoogle Scholar
  15. 15.
    Soon YY, Tham IWK, Lim KH et al (2014) Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD009454.pub2 CrossRefPubMedGoogle Scholar
  16. 16.
    Vanpouille-Box C, Alard A, Aryankalayil MJ et al (2017) DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun 8:1–15.  https://doi.org/10.1038/ncomms15618 CrossRefGoogle Scholar
  17. 17.
    Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395.  https://doi.org/10.1016/S1470-2045(14)70061-0 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Jürgen Dunst
    • 1
    Email author
  • Dirk Bauerschlag
    • 1
  • Nicolai Maass
    • 1
  • David Krug
    • 1
  1. 1.Klinik für StrahlentherapieUniversitätsklinikum Schleswig-HolsteinKielDeutschland

Personalised recommendations